Search
for

    Research 7 of 29

    1. Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling PloS one · 2014 · 56 citations
    2. Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer Cancer research · 2013 · 2 citations
    3. The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial Journal of cachexia, sarcopenia and muscle · 2011 · 306 citations
    4. In silico investigation of possible multi-target drugs against Glutamate S-transferase and prolyl tRNA synthetase in Onchocerca volvulus Open Access Research Journal of Biology and Pharmacy · 2026
    5. Androgen receptor: A promising therapeutic target in breast cancer Critical Reviews in Clinical Laboratory Sciences · 2019 · 21 citations
    6. Emerging medication for the treatment of male hypogonadism Expert Opinion on Emerging Drugs · 2012 · 77 citations
    7. Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus Journal of Endocrinology · 2019 · 19 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →